?
ПРИМЕНЕНИЕ БЕТА-АДРЕНОБЛОКАТОРОВ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ. АНАЛИЗ РЕЗУЛЬТАТА ОПРОСА ВРАЧЕЙ ЭКСПЕРТАМИ ЕВРАЗИЙСКОЙ АССОЦИАЦИИ ТЕРАПЕВТОВ
The use of beta-blockers (BB) plays a crucial role in the treatment of cardiovascular diseases. However, there are significant discrepancies with current guidelines in real-world practice. The main issues related to suboptimal dosing regimens and poor medication adherence reduce the effectiveness of therapy and worsen the prognosis of patients. Under the auspices of the Eurasian Association of Internal Medicine (EUIMA), a working group was convened on BB use in real-world practice. The working group aim was to draw attention to the issue of the correctness and specific features of BB prescription by practitioners. The initiative analyzed physician survey data encompassing BB prescription trends, drug selection criteria, class perception, and implementation barriers. The EUIMA working group discussed the survey results and proposed approaches to optimizing BB prescriptions in real-world practice.